Associations of Medications With Lower Odds of Typical COVID-19 Symptoms: Cross-Sectional Symptom Surveillance Study.

Dietmar Urbach Friedemann Awiszus Sven Leiß Tamsin Venton Alexander Vincent De Specht Christian J Apfelbacher

Published in: JMIR public health and surveillance (2020)

German Clinical Trials Register DRKS00022185; https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022185; World Health Organization International Clinical Trials Registry Platform U1111-1252-6946.

Keyphrases

clinical trial
phase ii
phase iii
study protocol
cross sectional
open label
coronavirus disease
sars cov
public health
double blind
high throughput
randomized controlled trial
single cell